| Metabolite |
Author-emphasized biomarkers |
Mean concentration (case) |
Mean concentration (control) |
Fold change (case/control) |
P-value |
FDR |
VIP |
| arginine |
– |
– |
– |
– |
0.02 |
– |
– |
| glutamic acid |
– |
– |
– |
– |
6.95e-03 |
– |
– |
| glutamic acid |
– |
– |
– |
– |
0.03 |
– |
– |
| glutamic acid |
– |
– |
– |
– |
5.85e-03 |
– |
– |
| glutamine |
– |
– |
– |
– |
0.04 |
– |
– |
| histidine |
– |
– |
– |
– |
3.35e-05 |
– |
– |
| histidine |
– |
– |
– |
– |
1.48e-03 |
– |
– |
| histidine |
– |
– |
– |
– |
7.84e-04 |
– |
– |
| leucine/isoleucine |
– |
– |
– |
– |
1.88e-03 |
– |
– |
| phenylalanine |
– |
– |
– |
– |
2.08e-05 |
– |
– |
| proline |
– |
– |
– |
– |
1.24e-04 |
– |
– |
| proline |
– |
– |
– |
– |
1.93e-04 |
– |
– |
| proline |
– |
– |
– |
– |
2.16e-04 |
– |
– |
| tryphophan |
– |
– |
– |
– |
2.25e-06 |
– |
– |
| tyrosine |
– |
– |
– |
– |
0.05 |
– |
– |
| methylhistidine |
– |
– |
– |
– |
3.71e-03 |
– |
– |
| acetylaspartic acid |
– |
– |
– |
– |
1.54e-03 |
– |
– |
| pyroglutamic acid |
– |
– |
– |
– |
1.27e-03 |
– |
– |
| pyroglutamic acid |
– |
– |
– |
– |
0.03 |
– |
– |
| taurine |
– |
– |
– |
– |
8.18e-04 |
– |
– |
| taurine |
– |
– |
– |
– |
1.58e-03 |
– |
– |
| taurine |
– |
– |
– |
– |
3.83e-03 |
– |
– |
| glutathione |
– |
– |
– |
– |
0.02 |
– |
– |
| glutathione |
– |
– |
– |
– |
9.47e-03 |
– |
– |
| glutathione |
– |
– |
– |
– |
5.15e-04 |
– |
– |
| guanosine |
– |
– |
– |
– |
0.03 |
– |
– |
| guanosine monophosphate |
– |
– |
– |
– |
3.27e-08 |
– |
– |
| inosine |
– |
– |
– |
– |
5.96e-03 |
– |
– |
| uracil |
– |
– |
– |
– |
6.61e-04 |
– |
– |
| uridine monophosphate (UMP) |
– |
– |
– |
– |
6.90e-08 |
– |
– |
| uridine diphosphate glucose |
– |
– |
– |
– |
1.73e-05 |
– |
– |
| adenosine monophosphate |
– |
– |
– |
– |
6.76e-05 |
– |
– |
| methylthioadenosine |
– |
– |
– |
– |
2.12e-04 |
– |
– |
| methylthioadenosine |
– |
– |
– |
– |
2.70e-04 |
– |
– |
| oxidized glutathione |
– |
– |
– |
– |
3.69e-05 |
– |
– |
| xantine |
– |
– |
– |
– |
0.01 |
– |
– |
| hypoxanthine |
– |
– |
– |
– |
1.02e-03 |
– |
– |
| L-threonic acid/hypoxanthine |
– |
– |
– |
– |
3.21e-03 |
– |
– |
| lactic acid |
– |
– |
– |
– |
0.02 |
– |
– |
| aminobutyric acid |
– |
– |
– |
– |
3.37e-03 |
– |
– |
| acetylneuraminic acid |
– |
– |
– |
– |
0.02 |
– |
– |
| Dipicolinic acid (DPA) |
– |
– |
– |
– |
2.12e-06 |
– |
– |
| lactic acid |
– |
– |
– |
– |
5.62e-06 |
– |
– |
| malic acid |
– |
– |
– |
– |
3.46e-05 |
– |
– |
| uric acid |
– |
– |
– |
– |
5.03e-03 |
– |
– |
| AMDA |
– |
– |
– |
– |
3.87e-03 |
– |
– |
| bilirubin |
– |
– |
– |
– |
5.82e-05 |
– |
– |
| bilirubin |
– |
– |
– |
– |
4.12e-05 |
– |
– |
| creatinine |
– |
– |
– |
– |
2.32e-03 |
– |
– |
| creatine |
– |
– |
– |
– |
1.62e-04 |
– |
– |
| creatine |
– |
– |
– |
– |
3.53e-03 |
– |
– |
| dihydrothymine |
– |
– |
– |
– |
0.04 |
– |
– |
| dimethylglycine |
– |
– |
– |
– |
4.23e-03 |
– |
– |
| ethanolamine phosphate |
– |
– |
– |
– |
3.20e-05 |
– |
– |
| ethanolamine phosphate |
– |
– |
– |
– |
4.19e-06 |
– |
– |
| phosphoethanolamine |
– |
– |
– |
– |
2.38e-04 |
– |
– |
| niacinamide |
– |
– |
– |
– |
4.27e-05 |
– |
– |
| nicotinamide |
– |
– |
– |
– |
3.31e-04 |
– |
– |
| stearamide |
– |
– |
– |
– |
0.03 |
– |
– |
| trimethylamine |
– |
– |
– |
– |
0.04 |
– |
– |
| glucose-6-phosphate |
– |
– |
– |
– |
0.03 |
– |
– |
| diacetylspermine |
– |
– |
– |
– |
2.75e-03 |
– |
– |
| acetylspermidine |
– |
– |
– |
– |
1.62e-05 |
– |
– |
| phytosphingosine |
– |
– |
– |
– |
0.02 |
– |
– |
| sphingosine |
– |
– |
– |
– |
9.20e-03 |
– |
– |
| sphingosine |
– |
– |
– |
– |
2.17e-03 |
– |
– |
| Glycerophospho-N-hexadecenyl Ethanolamine |
– |
– |
– |
– |
0.02 |
– |
– |
| adrenic acid |
– |
– |
– |
– |
6.90e-03 |
– |
– |
| arachidonic acid |
– |
– |
– |
– |
0.04 |
– |
– |
| arachidonic acid |
– |
– |
– |
– |
0.02 |
– |
– |
| arachidonic acid |
– |
– |
– |
– |
0.05 |
– |
– |
| docosahexaenoic acid |
– |
– |
– |
– |
1.21e-03 |
– |
– |
| eicosadienoic acid |
– |
– |
– |
– |
4.89e-05 |
– |
– |
| Eicosatrienoic acid (ETrE) |
– |
– |
– |
– |
1.59e-05 |
– |
– |
| oleic acid |
– |
– |
– |
– |
0.01 |
– |
– |
| palmitic acid |
– |
– |
– |
– |
0.02 |
– |
– |
| arachidoyl carnitine |
– |
– |
– |
– |
0.01 |
– |
– |
| arachidonoylcarnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| butyrylcarnitine |
– |
– |
– |
– |
3.75e-04 |
– |
– |
| butyrylcarnitine |
– |
– |
– |
– |
0.01 |
– |
– |
| eicosadienoylcarnitine |
– |
– |
– |
– |
8.91e-03 |
– |
– |
| docosadienoylcarnitine |
– |
– |
– |
– |
3.69e-03 |
– |
– |
| eicoseneoylcarnitine |
– |
– |
– |
– |
5.29e-03 |
– |
– |
| heptadecanoyl carnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| hexadecanoylcarnitine |
– |
– |
– |
– |
4.32e-03 |
– |
– |
| Hexadecenoylcarnitine |
– |
– |
– |
– |
1.31e-03 |
– |
– |
| hydroxyhexanoylcarnitine |
– |
– |
– |
– |
0.04 |
– |
– |
| hydroxyoctadecenoylcarnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| hydroxyvalerylcarnitine |
– |
– |
– |
– |
1.49e-03 |
– |
– |
| octadecadienylcarnitine |
– |
– |
– |
– |
0.01 |
– |
– |
| Octadecenoylcarnitine |
– |
– |
– |
– |
0.01 |
– |
– |
| octanoylcarnitine |
– |
– |
– |
– |
0.04 |
– |
– |
| Pentadecanoylcarnitine |
– |
– |
– |
– |
6.69e-03 |
– |
– |
| stearoylcarnitine |
– |
– |
– |
– |
6.21e-03 |
– |
– |
| tetradecanoylcarnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| Tetradecenoylcarnitine |
– |
– |
– |
– |
9.99e-03 |
– |
– |
| valerylcarnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| Galactosylceramide (d18:1/16:0)/Glucosylceramide (d18:1/16:0) |
– |
– |
– |
– |
1.63e-03 |
– |
– |
| LysoPA 18:1 |
– |
– |
– |
– |
8.73e-04 |
– |
– |
| LysoPC 14:0 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPC 14:0 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPC 15:0 |
– |
– |
– |
– |
1.81e-03 |
– |
– |
| LysoPC 15:0 |
– |
– |
– |
– |
3.30e-03 |
– |
– |
| LysoPC 16:0 |
– |
– |
– |
– |
9.75e-03 |
– |
– |
| LysoPC 16:0 sn1 |
– |
– |
– |
– |
9.16e-03 |
– |
– |
| LysoPC 16:0 sn1 |
– |
– |
– |
– |
0.01 |
– |
– |
| LysoPC 16:0 sn1 |
– |
– |
– |
– |
0.01 |
– |
– |
| LysoPC 16:0 sn2 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPC 16:0 sn2 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPC 16:0 sn2 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 16:1 sn1 |
– |
– |
– |
– |
3.92e-04 |
– |
– |
| LysoPC 16:1 sn2 |
– |
– |
– |
– |
5.22e-03 |
– |
– |
| LysoPC 16:1 sn2 |
– |
– |
– |
– |
0.01 |
– |
– |
| LysoPC 17:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 17:0 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPC 18:1 sn1 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPC 18:1 sn1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 18:1 sn2 |
– |
– |
– |
– |
4.44e-03 |
– |
– |
| LysoPC 18:2 |
– |
– |
– |
– |
8.15e-03 |
– |
– |
| LysoPC 18:2 sn1 |
– |
– |
– |
– |
0.01 |
– |
– |
| LysoPC 18:2 sn1 |
– |
– |
– |
– |
7.28e-03 |
– |
– |
| LysoPC 18:2 sn2 |
– |
– |
– |
– |
7.86e-04 |
– |
– |
| LysoPC 18:2 sn2 |
– |
– |
– |
– |
1.06e-03 |
– |
– |
| LysoPC 20:2 |
– |
– |
– |
– |
6.56e-03 |
– |
– |
| LysoPC 20:2 |
– |
– |
– |
– |
8.06e-03 |
– |
– |
| LysoPC 20:3 |
– |
– |
– |
– |
9.79e-03 |
– |
– |
| LysoPC 20:3 sn1 |
– |
– |
– |
– |
9.05e-03 |
– |
– |
| LysoPC 20:3 sn2 |
– |
– |
– |
– |
1.41e-04 |
– |
– |
| LysoPC 20:4 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 20:4 |
– |
– |
– |
– |
8.08e-03 |
– |
– |
| LysoPC 22:6 sn1 |
– |
– |
– |
– |
2.81e-03 |
– |
– |
| LysoPC 22:6 sn1 |
– |
– |
– |
– |
5.54e-04 |
– |
– |
| LysoPC 22:6 sn2 |
– |
– |
– |
– |
5.33e-05 |
– |
– |
| LysoPC 22:6 sn2 |
– |
– |
– |
– |
4.01e-04 |
– |
– |
| LysoPE 18:2 sn2 |
– |
– |
– |
– |
8.85e-04 |
– |
– |
| LysoPE 22:5 |
– |
– |
– |
– |
0.01 |
– |
– |
| LysoPE P-16:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPE P-17:0 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPG 18:0 |
– |
– |
– |
– |
0.05 |
– |
– |
| LysoPG 18:1 sn1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPG 18:1 sn2 |
– |
– |
– |
– |
1.28e-05 |
– |
– |
| LysoPG 18:2 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPG 20:4 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPG 22:6 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPI 16:0 |
– |
– |
– |
– |
7.60e-03 |
– |
– |
| LysoPI 18:0 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPI 18:1 sn1 |
– |
– |
– |
– |
8.12e-03 |
– |
– |
| LysoPI 18:2 |
– |
– |
– |
– |
6.95e-03 |
– |
– |
| LysoPI 20:3 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPI 20:3 sn2 |
– |
– |
– |
– |
8.79e-03 |
– |
– |
| LysoPI 20:4 sn2 |
– |
– |
– |
– |
2.91e-04 |
– |
– |
| PC 14:0/18:2; PC 16:1/16:1 |
– |
– |
– |
– |
8.89e-03 |
– |
– |
| PC 14:0/22:6 |
– |
– |
– |
– |
1.20e-03 |
– |
– |
| PC 15:0/20:4 |
– |
– |
– |
– |
0.02 |
– |
– |
| PC 16:0/18:2 |
– |
– |
– |
– |
0.01 |
– |
– |
| PC 16:1/20:4 |
– |
– |
– |
– |
9.46e-03 |
– |
– |
| PC 16:1/22:6 |
– |
– |
– |
– |
3.44e-04 |
– |
– |
| PC 17:0/20:4 |
– |
– |
– |
– |
0.03 |
– |
– |
| PC 18:0/22:6 |
– |
– |
– |
– |
8.74e-03 |
– |
– |
| PC 18:1/22:6 |
– |
– |
– |
– |
3.17e-03 |
– |
– |
| PC 18:1/22:6 |
– |
– |
– |
– |
3.32e-03 |
– |
– |
| PC 18:2/22:6 |
– |
– |
– |
– |
0.02 |
– |
– |
| PC 18:2/22:6 |
– |
– |
– |
– |
0.04 |
– |
– |
| PC 20:4/14:0 |
– |
– |
– |
– |
0.03 |
– |
– |
| PC 20:4/22:4 |
– |
– |
– |
– |
4.77e-04 |
– |
– |
| PC 29:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| PC 34:1 Plasm |
– |
– |
– |
– |
3.31e-03 |
– |
– |
| PC 35:1 |
– |
– |
– |
– |
9.01e-03 |
– |
– |
| PC 35:5 |
– |
– |
– |
– |
1.70e-03 |
– |
– |
| PC 36:6 |
– |
– |
– |
– |
5.45e-04 |
– |
– |
| PC 38:3 |
– |
– |
– |
– |
4.77e-03 |
– |
– |
| PC 38:3 |
– |
– |
– |
– |
0.01 |
– |
– |
| PC 38:5 |
– |
– |
– |
– |
5.07e-03 |
– |
– |
| PC 38:5 |
– |
– |
– |
– |
0.01 |
– |
– |
| PC 40:6 |
– |
– |
– |
– |
0.02 |
– |
– |
| PC 40:6 Plasm |
– |
– |
– |
– |
0.04 |
– |
– |
| PC 40:8 |
– |
– |
– |
– |
3.22e-03 |
– |
– |
| PC 40:9 |
– |
– |
– |
– |
2.10e-03 |
– |
– |
| PC 42:8 |
– |
– |
– |
– |
0.01 |
– |
– |
| PC P-18:0/22:6 |
– |
– |
– |
– |
0.03 |
– |
– |
| PC P-18:1/20:4 |
– |
– |
– |
– |
0.02 |
– |
– |
| PE 16:0/22:6 |
– |
– |
– |
– |
0.03 |
– |
– |
| PE 17:0/20:4 |
– |
– |
– |
– |
1.16e-03 |
– |
– |
| PE 32:2 |
– |
– |
– |
– |
0.03 |
– |
– |
| PE 36:5 |
– |
– |
– |
– |
5.83e-04 |
– |
– |
| SM 32:1 |
– |
– |
– |
– |
4.03e-03 |
– |
– |
| SM 35:1 |
– |
– |
– |
– |
0.02 |
– |
– |
| SM 35:1 |
– |
– |
– |
– |
3.14e-03 |
– |
– |
| SM (d18:1/18:0) |
– |
– |
– |
– |
4.12e-03 |
– |
– |
| SM(d18:0/16:0) |
– |
– |
– |
– |
6.36e-03 |
– |
– |
| SM(d18:1/12:0) |
– |
– |
– |
– |
3.33e-04 |
– |
– |
| SM(d18:1/12:0) |
– |
– |
– |
– |
1.58e-04 |
– |
– |
| SM(d18:2/14:0) |
– |
– |
– |
– |
8.32e-03 |
– |
– |
| SM(d18:2/14:0) |
– |
– |
– |
– |
0.02 |
– |
– |
| SM(d18:2/15:0) |
– |
– |
– |
– |
0.01 |
– |
– |
| glutamic acid |
– |
– |
– |
– |
1.28e-04 |
– |
– |
| glutamic acid |
– |
– |
– |
– |
1.95e-03 |
– |
– |
| glutamic acid |
– |
– |
– |
– |
0.02 |
– |
– |
| glutamine |
– |
– |
– |
– |
0.02 |
– |
– |
| histidine |
– |
– |
– |
– |
0.01 |
– |
– |
| histidine |
– |
– |
– |
– |
4.04e-03 |
– |
– |
| histidine |
– |
– |
– |
– |
0.02 |
– |
– |
| leucine |
– |
– |
– |
– |
1.57e-03 |
– |
– |
| leucine/isoleucine |
– |
– |
– |
– |
7.42e-03 |
– |
– |
| phenylalanine |
– |
– |
– |
– |
2.01e-04 |
– |
– |
| phenylalanine |
– |
– |
– |
– |
2.82e-03 |
– |
– |
| proline |
– |
– |
– |
– |
2.01e-03 |
– |
– |
| proline |
– |
– |
– |
– |
9.96e-04 |
– |
– |
| proline |
– |
– |
– |
– |
9.59e-05 |
– |
– |
| tryphophan |
– |
– |
– |
– |
2.92e-06 |
– |
– |
| tyrosine |
– |
– |
– |
– |
0.03 |
– |
– |
| valine |
– |
– |
– |
– |
1.39e-03 |
– |
– |
| methylhistidine |
– |
– |
– |
– |
4.08e-03 |
– |
– |
| acetylaspartic acid |
– |
– |
– |
– |
0.03 |
– |
– |
| pyroglutamic acid |
– |
– |
– |
– |
5.61e-03 |
– |
– |
| hydroxyglutaric acid |
– |
– |
– |
– |
8.60e-04 |
– |
– |
| betaina |
– |
– |
– |
– |
2.94e-03 |
– |
– |
| betaine |
– |
– |
– |
– |
0.03 |
– |
– |
| taurine |
– |
– |
– |
– |
0.02 |
– |
– |
| glutathione |
– |
– |
– |
– |
2.32e-03 |
– |
– |
| glutathione |
– |
– |
– |
– |
1.06e-03 |
– |
– |
| glutathione |
– |
– |
– |
– |
7.97e-04 |
– |
– |
| guanosine |
– |
– |
– |
– |
3.26e-04 |
– |
– |
| guanosine monophosphate |
– |
– |
– |
– |
1.73e-07 |
– |
– |
| uracil |
– |
– |
– |
– |
0.02 |
– |
– |
| uridine monophosphate (UMP) |
– |
– |
– |
– |
2.26e-06 |
– |
– |
| uridine diphosphate glucose |
– |
– |
– |
– |
5.65e-04 |
– |
– |
| adenosine monophosphate |
– |
– |
– |
– |
1.22e-06 |
– |
– |
| methylthioadenosine |
– |
– |
– |
– |
1.49e-03 |
– |
– |
| methylthioadenosine |
– |
– |
– |
– |
2.57e-04 |
– |
– |
| oxidized glutathione |
– |
– |
– |
– |
5.65e-04 |
– |
– |
| xantine |
– |
– |
– |
– |
4.96e-04 |
– |
– |
| hypoxanthine |
– |
– |
– |
– |
1.26e-03 |
– |
– |
| lactic acid |
– |
– |
– |
– |
0.01 |
– |
– |
| aminobutyric acid |
– |
– |
– |
– |
7.76e-04 |
– |
– |
| lactic acid |
– |
– |
– |
– |
7.25e-06 |
– |
– |
| malic acid |
– |
– |
– |
– |
6.18e-04 |
– |
– |
| AMDA |
– |
– |
– |
– |
8.38e-04 |
– |
– |
| bilirubin |
– |
– |
– |
– |
3.86e-06 |
– |
– |
| bilirubin |
– |
– |
– |
– |
4.85e-08 |
– |
– |
| creatinine |
– |
– |
– |
– |
2.88e-05 |
– |
– |
| creatine |
– |
– |
– |
– |
4.68e-04 |
– |
– |
| creatine |
– |
– |
– |
– |
5.07e-06 |
– |
– |
| dihydrothymine |
– |
– |
– |
– |
0.01 |
– |
– |
| dimethylglycine |
– |
– |
– |
– |
0.02 |
– |
– |
| ethanolamine phosphate |
– |
– |
– |
– |
1.67e-05 |
– |
– |
| ethanolamine phosphate |
– |
– |
– |
– |
1.05e-04 |
– |
– |
| phosphoethanolamine |
– |
– |
– |
– |
1.10e-03 |
– |
– |
| niacinamide |
– |
– |
– |
– |
4.77e-05 |
– |
– |
| nicotinamide |
– |
– |
– |
– |
5.44e-04 |
– |
– |
| acetylspermidine |
– |
– |
– |
– |
9.69e-04 |
– |
– |
| phytosphingosine |
– |
– |
– |
– |
3.27e-03 |
– |
– |
| sphingosine |
– |
– |
– |
– |
0.04 |
– |
– |
| sphingosine |
– |
– |
– |
– |
1.65e-04 |
– |
– |
| piperidine |
– |
– |
– |
– |
3.64e-03 |
– |
– |
| adrenic acid |
– |
– |
– |
– |
1.69e-05 |
– |
– |
| adrenic acid |
– |
– |
– |
– |
5.84e-04 |
– |
– |
| docosahexaenoic acid |
– |
– |
– |
– |
5.18e-03 |
– |
– |
| eicosadienoic acid |
– |
– |
– |
– |
4.81e-06 |
– |
– |
| eicosapentaenoic acid |
– |
– |
– |
– |
0.05 |
– |
– |
| Eicosatrienoic acid (ETrE) |
– |
– |
– |
– |
1.83e-03 |
– |
– |
| acetylcarnitine |
– |
– |
– |
– |
0.05 |
– |
– |
| arachidonoylcarnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| butyrylcarnitine |
– |
– |
– |
– |
1.67e-03 |
– |
– |
| butyrylcarnitine |
– |
– |
– |
– |
1.84e-03 |
– |
– |
| carnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| eicosadienoylcarnitine |
– |
– |
– |
– |
9.22e-06 |
– |
– |
| docosadienoylcarnitine |
– |
– |
– |
– |
2.98e-06 |
– |
– |
| eicoseneoylcarnitine |
– |
– |
– |
– |
2.61e-04 |
– |
– |
| heptadecanoyl carnitine |
– |
– |
– |
– |
1.23e-03 |
– |
– |
| hexadecanoylcarnitine |
– |
– |
– |
– |
2.90e-04 |
– |
– |
| Hexadecenoylcarnitine |
– |
– |
– |
– |
3.06e-04 |
– |
– |
| Hexadecenoylcarnitine |
– |
– |
– |
– |
5.02e-03 |
– |
– |
| hydroxybutyrylcarnitine |
– |
– |
– |
– |
2.63e-03 |
– |
– |
| hydroxyhexadecanoylcarnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| hydroxymyristoylcarnitine |
– |
– |
– |
– |
7.02e-03 |
– |
– |
| hydroxyoctadecenoylcarnitine |
– |
– |
– |
– |
1.97e-04 |
– |
– |
| hydroxyoctanoyl carnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| hydroxytetradecenoylcarnitine |
– |
– |
– |
– |
1.05e-03 |
– |
– |
| hydroxyvalerylcarnitine |
– |
– |
– |
– |
2.36e-06 |
– |
– |
| octadecadienylcarnitine |
– |
– |
– |
– |
0.04 |
– |
– |
| octadecadienylcarnitine |
– |
– |
– |
– |
1.06e-04 |
– |
– |
| Octadecenoylcarnitine |
– |
– |
– |
– |
1.22e-04 |
– |
– |
| Octadecenoylcarnitine |
– |
– |
– |
– |
3.78e-04 |
– |
– |
| octanoylcarnitine |
– |
– |
– |
– |
0.04 |
– |
– |
| Pentadecanoylcarnitine |
– |
– |
– |
– |
1.91e-05 |
– |
– |
| propionylcarnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| tetradecanoylcarnitine |
– |
– |
– |
– |
9.08e-04 |
– |
– |
| Tetradecenoylcarnitine |
– |
– |
– |
– |
8.98e-03 |
– |
– |
| Galactosylceramide (d18:1/16:0)/Glucosylceramide (d18:1/16:0) |
– |
– |
– |
– |
4.38e-04 |
– |
– |
| LysoPC 15:0 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPC 15:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 16:1 Plasm |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPC 16:1 sn1 |
– |
– |
– |
– |
3.67e-04 |
– |
– |
| LysoPC 16:1 sn1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 16:1 sn2 |
– |
– |
– |
– |
2.55e-03 |
– |
– |
| LysoPC 16:1 sn2 |
– |
– |
– |
– |
1.93e-03 |
– |
– |
| LysoPC 18:1 sn2 |
– |
– |
– |
– |
2.22e-03 |
– |
– |
| LysoPC 18:1 sn2 |
– |
– |
– |
– |
1.84e-04 |
– |
– |
| LysoPC 18:2 sn2 |
– |
– |
– |
– |
4.49e-05 |
– |
– |
| LysoPC 18:2 sn2 |
– |
– |
– |
– |
8.72e-05 |
– |
– |
| LysoPC 20:1 |
– |
– |
– |
– |
3.90e-03 |
– |
– |
| LysoPC 20:2 |
– |
– |
– |
– |
4.28e-07 |
– |
– |
| LysoPC 20:2 |
– |
– |
– |
– |
1.41e-04 |
– |
– |
| LysoPC 20:3 |
– |
– |
– |
– |
6.30e-03 |
– |
– |
| LysoPC 20:3 sn1 |
– |
– |
– |
– |
9.29e-03 |
– |
– |
| LysoPC 20:3 sn2 |
– |
– |
– |
– |
1.38e-05 |
– |
– |
| LysoPC 20:4 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 22:6 sn2 |
– |
– |
– |
– |
2.78e-06 |
– |
– |
| LysoPC 22:6 sn2 |
– |
– |
– |
– |
2.46e-06 |
– |
– |
| LysoPC O-16:1 / LysoPC P-16:0 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPE 16:0 sn1 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPE 16:0 sn1 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPE 16:0 sn2 |
– |
– |
– |
– |
2.65e-03 |
– |
– |
| LysoPE 16:0 sn2 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPE 16:1 |
– |
– |
– |
– |
7.91e-03 |
– |
– |
| LysoPE 18:0 sn2 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPE 18:2 sn2 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPE 20:4 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPE 22:6 |
– |
– |
– |
– |
8.26e-03 |
– |
– |
| LysoPE P-17:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPG 18:0 |
– |
– |
– |
– |
9.06e-03 |
– |
– |
| LysoPG 18:1 sn1 |
– |
– |
– |
– |
2.93e-03 |
– |
– |
| LysoPG 18:1 sn2 |
– |
– |
– |
– |
4.84e-03 |
– |
– |
| LysoPI 18:1 sn2 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPI 18:2 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPI 20:3 sn1 |
– |
– |
– |
– |
4.03e-04 |
– |
– |
| LysoPI 20:3 sn2 |
– |
– |
– |
– |
9.96e-06 |
– |
– |
| LysoPI 20:4 sn2 |
– |
– |
– |
– |
6.38e-05 |
– |
– |
| PC 14:0/22:6 |
– |
– |
– |
– |
0.04 |
– |
– |
| PC 15:0/20:4 |
– |
– |
– |
– |
7.39e-04 |
– |
– |
| PC 16:1/22:6 |
– |
– |
– |
– |
0.02 |
– |
– |
| PC 17:0/20:4 |
– |
– |
– |
– |
0.01 |
– |
– |
| PC 18:0/22:6 |
– |
– |
– |
– |
5.80e-05 |
– |
– |
| PC 18:1/22:6 |
– |
– |
– |
– |
1.87e-03 |
– |
– |
| PC 18:2/22:6 |
– |
– |
– |
– |
1.01e-03 |
– |
– |
| PC 18:2/22:6 |
– |
– |
– |
– |
8.81e-03 |
– |
– |
| PC 20:4/22:4 |
– |
– |
– |
– |
3.71e-05 |
– |
– |
| PC 20:4/22:6 |
– |
– |
– |
– |
0.02 |
– |
– |
| PC 35:1 |
– |
– |
– |
– |
0.05 |
– |
– |
| PC 35:5 |
– |
– |
– |
– |
7.95e-05 |
– |
– |
| PC 36:4 Plasm |
– |
– |
– |
– |
0.05 |
– |
– |
| PC 36:6 |
– |
– |
– |
– |
6.35e-03 |
– |
– |
| PC 38:3 |
– |
– |
– |
– |
0.03 |
– |
– |
| PC 38:3 |
– |
– |
– |
– |
0.03 |
– |
– |
| PC 38:5 |
– |
– |
– |
– |
3.70e-05 |
– |
– |
| PC 38:5 |
– |
– |
– |
– |
0.02 |
– |
– |
| PC 38:5 |
– |
– |
– |
– |
0.03 |
– |
– |
| PC 40:6 |
– |
– |
– |
– |
0.03 |
– |
– |
| PC 40:6 |
– |
– |
– |
– |
0.03 |
– |
– |
| PC 42:8 |
– |
– |
– |
– |
2.89e-04 |
– |
– |
| PC P-16:0/18:2 |
– |
– |
– |
– |
7.50e-03 |
– |
– |
| PC P-18:0/22:6 |
– |
– |
– |
– |
4.86e-03 |
– |
– |
| PE 32:2 |
– |
– |
– |
– |
0.03 |
– |
– |
| SM 36:2 |
– |
– |
– |
– |
2.94e-03 |
– |
– |
| SM (d18:1/18:0) |
– |
– |
– |
– |
0.02 |
– |
– |
| SM(d18:0/16:0) |
– |
– |
– |
– |
0.02 |
– |
– |
| SM(d18:1/12:0) |
– |
– |
– |
– |
0.02 |
– |
– |
| SM(d18:1/12:0) |
– |
– |
– |
– |
0.03 |
– |
– |
| valine |
– |
– |
– |
– |
0.01 |
– |
– |
| acetylaspartic acid |
– |
– |
– |
– |
0.03 |
– |
– |
| hydroxyglutaric acid |
– |
– |
– |
– |
0.03 |
– |
– |
| taurine |
– |
– |
– |
– |
0.05 |
– |
– |
| taurine |
– |
– |
– |
– |
0.02 |
– |
– |
| taurine |
– |
– |
– |
– |
0.04 |
– |
– |
| guanosine |
– |
– |
– |
– |
1.85e-03 |
– |
– |
| inosine |
– |
– |
– |
– |
0.02 |
– |
– |
| xantine |
– |
– |
– |
– |
0.04 |
– |
– |
| L-threonic acid/hypoxanthine |
– |
– |
– |
– |
0.03 |
– |
– |
| uric acid |
– |
– |
– |
– |
0.03 |
– |
– |
| creatinine |
– |
– |
– |
– |
0.02 |
– |
– |
| creatine |
– |
– |
– |
– |
9.83e-03 |
– |
– |
| creatine |
– |
– |
– |
– |
4.07e-03 |
– |
– |
| dihydrothymine |
– |
– |
– |
– |
0.03 |
– |
– |
| ethanolamine phosphate |
– |
– |
– |
– |
0.05 |
– |
– |
| ethanolamine phosphate |
– |
– |
– |
– |
0.02 |
– |
– |
| trimethylamine |
– |
– |
– |
– |
0.04 |
– |
– |
| Glycerophospho-(N-acyl)-ethanolamine |
– |
– |
– |
– |
0.02 |
– |
– |
| glycerophospho-N-heptacenyl ethanolamine |
– |
– |
– |
– |
0.01 |
– |
– |
| Glycerophospho-N-heptadecanoyl Ethanolamine |
– |
– |
– |
– |
7.88e-03 |
– |
– |
| Glycerophospho-N-hexadecenyl Ethanolamine |
– |
– |
– |
– |
0.02 |
– |
– |
| glycerophospho-N-octadecanoyl ethanolamine |
– |
– |
– |
– |
0.01 |
– |
– |
| Glycerophospho-N-octadecenyl Ethanolamine |
– |
– |
– |
– |
0.05 |
– |
– |
| arachidonic acid |
– |
– |
– |
– |
0.03 |
– |
– |
| arachidonic acid |
– |
– |
– |
– |
0.02 |
– |
– |
| arachidonic acid |
– |
– |
– |
– |
0.03 |
– |
– |
| docosahexaenoic acid |
– |
– |
– |
– |
0.03 |
– |
– |
| eicosapentaenoic acid |
– |
– |
– |
– |
0.02 |
– |
– |
| Eicosatrienoic acid (ETrE) |
– |
– |
– |
– |
0.03 |
– |
– |
| carnitine |
– |
– |
– |
– |
0.02 |
– |
– |
| hydroxyoctanoyl carnitine |
– |
– |
– |
– |
0.03 |
– |
– |
| octadecadienylcarnitine |
– |
– |
– |
– |
0.01 |
– |
– |
| LysoPA 18:1 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPC 15:0 |
– |
– |
– |
– |
0.01 |
– |
– |
| LysoPC 15:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 16:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 16:0 sn1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 16:0 sn1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 16:0 sn1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 16:0 sn2 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 16:0 sn2 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPC 16:0 sn2 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 16:1 Plasm |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 17:0 |
– |
– |
– |
– |
0.01 |
– |
– |
| LysoPC 17:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 18:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 18:0 sn1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 18:0 sn1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 18:0 sn2 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 18:0 sn2 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPC 18:1 sn1 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPC 18:1 sn1 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPC 18:2 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPC 18:2 sn1 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPC 18:2 sn1 |
– |
– |
– |
– |
0.05 |
– |
– |
| LysoPC 18:2 sn2 |
– |
– |
– |
– |
0.05 |
– |
– |
| LysoPE 16:0 sn1 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPE 16:0 sn1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPE 16:0 sn2 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPE 17:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPE 18:0 sn1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPE 18:0 sn2 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPE 18:1 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPE 18:2 sn1 |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPE 22:4 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPE 22:5 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPE P-16:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPI 16:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| LysoPI 18:0 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPI 18:1 sn1 |
– |
– |
– |
– |
0.04 |
– |
– |
| LysoPI 18:2 |
– |
– |
– |
– |
0.05 |
– |
– |
| LysoPI 20:3 |
– |
– |
– |
– |
0.04 |
– |
– |
| PC 16:1/20:4 |
– |
– |
– |
– |
0.02 |
– |
– |
| PE 17:0/20:4 |
– |
– |
– |
– |
0.04 |
– |
– |
| SM 36:2 |
– |
– |
– |
– |
0.05 |
– |
– |
| PC 40:7 |
– |
– |
– |
– |
0.02 |
– |
– |
| PE P-16:0/18:2 |
– |
– |
– |
– |
0.02 |
– |
– |
| PC 36:0 Plasm |
– |
– |
– |
– |
0.03 |
– |
– |
| LysoPC 18:3 |
– |
– |
– |
– |
0.03 |
– |
– |
| PE P-16:0/18:2 |
– |
– |
– |
– |
9.55e-04 |
– |
– |
| SM(d18:2/15:0) |
– |
– |
– |
– |
0.02 |
– |
– |
| PE P-18:1/20:4; PE P-16:0/22:5 |
– |
– |
– |
– |
0.03 |
– |
– |
| PE 20:4/P-18:0 |
– |
– |
– |
– |
2.56e-03 |
– |
– |
| PC O-16:1/18:2 |
– |
– |
– |
– |
9.55e-04 |
– |
– |
| PC 20:5/P-16:0 |
– |
– |
– |
– |
0.02 |
– |
– |
| PC 15:0/22:6 |
– |
– |
– |
– |
0.02 |
– |
– |
| PC 18:1/22:6 |
– |
– |
– |
– |
0.02 |
– |
– |